Page 14 - GALENIKA MEDICAL JOURNAL

25. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health 32. Lehmann J, Suttmann H, Kovac I, Hack M, Kamradt J, Siemer S, et al.
Organization/International Society of Urological Pathology consensus Transitional cell carcinoma of the ureter: prognostic factors influencing
classification of urothelial (transitional cell) neoplasms of the urinary progression and survival. Eur Urol. 2007 May; 51(5):1281-8.
bladder. Bladder Consensus Conference Committee. Am J Surg Pathol.
1998 Dec; 22(12):1435-48. 33. Zigeuner R, Pummer K. Urothelial carcinoma of the upper urinary tract:
surgical approach and prognostic factors. Eur Urol. 2008 Apr; 53(4):720-
26. Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CP, Swanson DA, et al. 31.
Nephroureterectomy for treating upper urinary tract transitional cell
carcinoma: Time to change the treatment paradigm? BJU Int. 2006 Dec; 34. Soga N, Arima K, Sugimura Y. Adjuvant methotrexate, vinblastine,
98(6):1176-80. adriamycin, and cisplatin chemotherapy has potential to prevent
recurrence of bladder tumors after surgical removal of upper urinary
27. Wu Y, Dong Q, Liu L, Han P, Wei Q. The impact of tumor location and tract transitional cell carcinoma. Int J Urol. 2008 Sep; 15(9):800-3.
multifocality on prognosis for patients with upper tract urothelial
carcinoma: a meta-analysis. Sci Rep. 2014 Sep 15; 4:6361. 35. Vassilakopoulou M, de la Motte Rouge T, Colin P, Ouzzane A, Khayat
D, Dimopoulos MA, et al; French Collaborative National Database on
28. Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic UUT-UCC. Outcomes after adjuvant chemotherapy in the treatment
A, Nikic P, et al. Prognostic significance of non-muscle-invasive bladder of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC):
tumor history in patients with upper urinary tract urothelial carcinoma. results from a large multicenter collaborative study. Cancer. 2011 Dec
Urol Oncol. 2013 Nov; 31(8):1615-20. 15; 117(24):5500-8.
29. Milojevic B, Djokic M, Sipetic-Grujicic S, Milenkovic-Petronic D, 36. Hellenthal NJ, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M,
Vuksanovic A, Bumbasirevic U, et al. Upper urinary tract transitional cell Bolenz C, et al. Adjuvant chemotherapy for high risk upper tract
carcinoma: location is not correlated with prognosis. BJU Int. 2012 Apr; urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma
109(7):1037-42. Collaboration. J Urol. 2009 Sep;182(3):900-6.
30. Milojevic B, Dzamic Z, Grozdic Milojevic I, Bumbasirevic U, Santric V,
Kajmakovic B, et al. Prognostic value of Balkan endemic nephropathy
and gender on upper tract urothelial carcinoma outcomes after radical Konflikt interesa: Nema
nephroureterectomy: A cohort study. Urol Oncol. 2021 Nov; 39(11):786.
e9-786.e16. Primljeno: 20. 02. 2023.
31. Novara G, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Bastian Prihvaćeno: 07. 03. 2023.
PJ, et al. Prognostic role of lymphovascular invasion in patients with Onlajn: 01. 06. 2023.
urothelial carcinoma of the upper urinary tract: an international
validation study. Eur Urol. 2010 Jun; 57(6):1064-71.

12 DOI: 10.5937/Galmed2306006D